Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) has settled another lawsuit alleging price fixing in the US. Teva ...

US law firm Morgan Lewis & Bockius has hired Tim Powell, the co-founder of boutique IP firm Powell Gilbert, as a partner in ...

A decision in the 2013 U.S. Supreme Court case FTC v. Actavis found that while brand companies can be sued for engaging in reverse-payment, the payments themselves are not presumptively illegal.

Two of the most notable examples of this in recent years are Actavis (now owner of Allergan and to take Allergan's name globally) and Gilead. Actavis was a generics giant whose rise mirrors the ...

When he tells you about smuggling Actavis in lotion bottles, he enunciates every word like an MC plucked from a different generation, and the pockets he finds in these sturdy instrumentals are ...

Allergan, meanwhile, has been one of the sector's most frenzied deal-makers, having agreed its acquisition by generics firm Actavis for $70 billion barely a year ago. Brent Saunders has been ...

This was the agency’s approach in “pay-for-delay” cases (branded drugs compensating generics to delay entry) that resulted in ...

A greater proportion of women in the intervention group reported tolerable pain during placement and expressed a willingness ...

The luxury gin brand has teamed up with the Italian shoe company on its first apparel collection, inspired by the brands' ...

Global Adrenogenital Syndrome Treatment MarketThe global Adrenogenital Syndrome Treatment Market is expected to achieve significant growth, reaching a market value of USD 12.81 billion in 2023. With a ...

© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.

Michael L. Krychman, MD; Jan L. Shifren, MD, NCMP; James H. Liu, MD; Sheryl L. Kingsberg, PhD; Wulf H. Utian, MB BCh, PhD, DSc(Med), FRCOG, FACOG, FICS ...